ADBE vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Adobe Inc. and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Adobe Inc. · Technology
$238.25
+13.5% upside to fair value
Med Conviction
Grade B
High Quality
VS
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
ADBE has more upside to fair value
(+13.5%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ADBE |
JNJ |
| Current Price |
$238.25 |
$270.68 |
| Fair Value Estimate |
$270.38 |
$286.05 |
| Upside to Fair Value |
+13.5%
|
+5.7%
|
| Market Cap |
$94.7B |
$652.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
9.5x
|
20.2x
|
| Price / Sales |
3.6x
|
6.7x
|
| Price / FCF |
8.6x
|
35.3x
|
| Revenue Growth YoY |
+12.9%
|
+6.6%
|
| Gross Margin |
89.1%
|
67.9%
|
| Operating Margin |
35.7%
|
26.8%
|
| Return on Equity |
62.9%
|
25.7%
|
| Dividend Yield |
0% |
1.95% |
| FCF Yield |
11.63%
|
2.83%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Adobe is a global software provider organized into Digital Media, Digital Experience, and Publishing and Advertising, with Creative Cloud as its subscription flagship and Document Cloud as its cloud-native document platform. The business quality is high on fundamentals: TTM gross margin of 89.1%, TTM operating margin of 35.7%, TTM net margin of 28.0%, ROE of 62.9%, and free cash flow of $27.69 pe…
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Accumulation Zones
| Metric |
ADBE |
JNJ |
| Zone Low |
$202.78 |
$214.54 |
| Zone High |
$229.82 |
$243.14 |
| In Buy Zone? |
No
|
No
|